STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Revenue growth
-14.4%
XBRL, annual
Net margin
4.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.7M
four quarters, 2025-07-01 to 2026-06-30
History
FY Mar 2026
$6.3M
FY Mar 2025
$7.4M
FY Mar 2024
$9.1M
FY Mar 2023
n/a
Jun 2026
$1.7M
Mar 2026
$1.6M
Dec 2025
$754.9K
Sep 2025
$1.5M
Jun 2025
$2.4M
Mar 2025
$1.3M
Dec 2024
$701.1K
Sep 2024
$2.3M
At each fiscal year end
Single quarter
Net margin, TTM
-2.1%
net income over revenue, 2025-07-01 to 2026-06-30
History
FY Mar 2026
+4.0%
FY Mar 2025
n/a
FY Mar 2024
+48.8%
FY Mar 2023
n/a
Jun 2026
+4.3%
Mar 2026
+1.1%
Dec 2025
-27.9%
Sep 2025
+0.1%
Jun 2025
+18.4%
Mar 2025
-9.2%
Dec 2024
-31.8%
Sep 2024
+19.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$325.4K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
History
FY Mar 2026
$77.7K
FY Mar 2025
$2.4M
FY Mar 2024
$952.0K
FY Mar 2023
n/a
Jun 2026
$21.9K
Mar 2026
-$170.4K
Dec 2025
-$228.7K
Sep 2025
$51.8K
Jun 2025
$425.0K
Mar 2025
-$209.2K
Dec 2024
-$168.9K
Sep 2024
$1.5M
At each fiscal year end
Single quarter
Debt to equity
0.00x
current debt only, 2026-03-31; equity 2026-06-30
History
FY Mar 2026
0.00x
FY Mar 2025
0.00x
FY Mar 2024
n/a
FY Mar 2023
n/a
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
History
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-1.5%
TTM net income over average of 2025-06-30 and 2026-06-30
History
FY Mar 2026
+3.2%
FY Mar 2025
n/a
FY Mar 2024
+81.2%
FY Mar 2023
n/a
Jun 2026
-1.5%
Mar 2026
+3.2%
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+51.2%
Sep 2024
+45.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
History
FY Mar 2026
+2.8%
FY Mar 2025
n/a
FY Mar 2024
+74.0%
FY Mar 2023
n/a
Jun 2026
-1.2%
Mar 2026
+2.8%
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+44.0%
Sep 2024
+35.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
History
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
History
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
+50.0%
FY Mar 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+23.6%
Sep 2024
+20.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
36.00x
close 2026-10-09 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
History
FY Mar 2026
22.29x
FY Mar 2025
21.33x
FY Mar 2024
57.00x
FY Mar 2023
n/a
Jun 2026
39.50x
Mar 2026
22.29x
Dec 2025
13.00x
Sep 2025
14.00x
Jun 2025
13.00x
Mar 2025
21.33x
Dec 2024
96.00x
Sep 2024
96.00x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$11.3M
market value at close 2026-10-09 on 2026-08-14 shares, plus current debt only, 2026-03-31, minus cash 2026-03-31
History
FY Mar 2026
$179.9M
FY Mar 2025
$231.4M
FY Mar 2024
n/a
FY Mar 2023
n/a
Jun 2026
$12.6M
Mar 2026
$179.9M
Dec 2025
$180.7M
Sep 2025
$195.2M
Jun 2025
$186.6M
Mar 2025
$231.4M
Dec 2024
$353.9M
Sep 2024
$354.5M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-2.3%
TTM free cash flow over market value at close 2026-10-09
History
FY Mar 2026
+0.0%
FY Mar 2025
+1.0%
FY Mar 2024
+0.3%
FY Mar 2023
n/a
Jun 2026
-2.1%
Mar 2026
+0.0%
Dec 2025
+0.0%
Sep 2025
+0.0%
Jun 2025
+0.8%
Mar 2025
+1.0%
Dec 2024
+0.6%
Sep 2024
+0.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -67%, PEG needs growth
History
FY Mar 2026
n/a
FY Mar 2025
0.17x
FY Mar 2024
n/a
FY Mar 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
0.04x
Sep 2025
0.05x
Jun 2025
0.06x
Mar 2025
0.17x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-09. Hover a figure to see how it was computed.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
PCSV ranks highest on financial health (99th percentile) and profitability (40th), and lowest on growth (15th), among Services peers.
Profitability
40
Inputs
Return on equity-1.5% · 36 pct, sector of 209
Return on assets-1.2% · 44 pct, sector of 270
Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 229
Cash flow to debtno debt to cover
Growth
15
Inputs
Revenue growth, YoY-14.4% · 15 pct, sector of 343
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
4 not measured: Insider conviction, Institutional and government, Risk and compliance, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
No password to create and no card required. We store your email address and nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in. Google Analytics and
Microsoft Clarity load only if you allow them here, to show us which datasets matter.
No ad trackers, ever. Details in the privacy
policy.